Goldsmith provides analysis on Welltower's fundamentals, naming Omega Healthcare a buy-rated name, while UBS remains bullish on the subsector.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Goldsmith provides analysis on Welltower's fundamentals, naming Omega Healthcare a buy-rated name, while UBS remains bullish on the subsector.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Welltower
Real estate investment trust
- Omega Healthcare
-
UBS
Swiss multinational investment bank and financial services company